BOSTON SCIENTIFIC CORP (BSX)

US1011371077 - Common Stock

73.425  +0.16 (+0.23%)

Buy % Consensus

85

ChartMill assigns a Buy % Consensus number of 85% to BSX. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 74.98. This target is 2.11% above the current price.
BSX was analyzed by 37 analysts. The buy percentage consensus is at 85. So analysts seem to be very confident about BSX.
In the previous month the buy percentage consensus was at a similar level.
BSX was analyzed by 37 analysts, which is quite many. So the average rating should be quite meaningful.

Price Target & Forecast

Price Low Median Mean High 73.4363.6374.4674.9885.05 - -13.34% 1.41% 2.11% 15.83%
Up and Down Grades
Date Firm Action Rating
2024-04-26 Barclays Maintains Overweight -> Overweight
2024-04-25 Mizuho Maintains Buy -> Buy
2024-04-25 UBS Maintains Buy -> Buy
2024-04-25 Deutsche Bank Maintains Hold -> Hold
2024-04-25 RBC Capital Maintains Outperform -> Outperform
2024-04-25 Wells Fargo Maintains Overweight -> Overweight
2024-04-25 Evercore ISI Group Maintains Outperform -> Outperform
2024-04-25 Raymond James Maintains Strong Buy -> Strong Buy
2024-04-25 JP Morgan Maintains Overweight -> Overweight
2024-04-25 Baird Maintains Outperform -> Outperform
2024-04-25 Citigroup Maintains Buy -> Buy
2024-04-24 Needham Maintains Buy -> Buy
2024-04-15 RBC Capital Maintains Outperform -> Outperform
2024-04-04 Evercore ISI Group Maintains Outperform -> Outperform
2024-04-03 Argus Research Maintains Buy -> Buy
2024-04-03 Citigroup Maintains Buy -> Buy
2024-03-07 TD Cowen Maintains Outperform -> Outperform
2024-02-05 RBC Capital Reiterate Outperform -> Outperform
2024-02-01 Mizuho Upgrade Neutral -> Buy
2024-02-01 Needham Maintains Buy -> Buy
2024-02-01 Oppenheimer Maintains Perform -> Perform
2024-02-01 RBC Capital Maintains Outperform -> Outperform
2024-02-01 Wells Fargo Maintains Overweight -> Overweight
2024-02-01 Raymond James Maintains Strong Buy -> Strong Buy
2024-02-01 JP Morgan Maintains Overweight -> Overweight
2024-02-01 Citigroup Maintains Buy -> Buy
2024-01-16 RBC Capital Reiterate Outperform -> Outperform
2024-01-03 Raymond James Maintains Strong Buy -> Strong Buy
2023-12-29 BTIG Reiterate Buy -> Buy
2023-12-29 Wells Fargo Reiterate Overweight -> Overweight